Assertio Therapeutics Inc
(ASRT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 124,961 | 152,069 | 156,234 | 111,014 | 106,275 |
| Cost of Goods | 39,227 | 27,020 | 18,748 | 15,832 | 19,872 |
| Gross Profit | 85,734 | 125,049 | 137,486 | 95,182 | 86,403 |
| Operating Expenses | 110,437 | 368,605 | 98,829 | 86,590 | 169,430 |
| Operating Income | -24,476 | -243,536 | 39,405 | 9,424 | -82,155 |
| Interest Expense | 3,039 | 3,380 | 7,961 | 10,220 | 15,926 |
| Other Income | 5,986 | -7,138 | -278 | 243 | 52,568 |
| Pre-tax Income | -21,529 | -254,054 | 31,166 | -553 | -45,513 |
| Income Tax | 52 | 77,888 | -78,459 | 728 | -17,369 |
| Net Income Continuous | -21,581 | -331,942 | 109,625 | -1,281 | -28,144 |
| Net Income | $-21,581 | $-331,942 | $109,625 | $-1,281 | $-28,144 |
| EPS Basic Total Ops | -3.45 | -70.02 | 34.93 | -0.45 | -16.04 |
| EPS Basic Continuous Ops | -3.40 | -70.06 | 34.97 | -0.44 | -16.10 |
| EPS Diluted Total Ops | -3.45 | -70.02 | 30.43 | -0.45 | -16.04 |
| EPS Diluted Continuous Ops | -3.40 | -70.06 | 30.06 | -0.44 | -16.10 |
| EPS Diluted Before Non-Recurring Items | -3.45 | 6.75 | 30.43 | -0.45 | -16.19 |
| EBITDA(a) | $1,792 | $-214,852 | $73,105 | $38,695 | $-50,044 |